EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

St. John’s Wort Formulations Induce Rat CYP3A23-3A1 Independent of Their Hyperforin Content

Anima M Schäfer, Marta A Rysz, Julia Schädeli, Michelle Hübscher, Haleh Khosravi, Michelle Fehr, Isabell Seibert, Olivier Potterat, Martin Smieško, Henriette E Meyer Zu Schwabedissen iD

Molecular Pharmacology · 2024

DOI: 10.1124/molpharm.123.000725 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Pharmacology, 2024. Verfasst von Anima M Schäfer und 9 weiteren Autor:innen. Beteiligte Einrichtung: Biopharmacy (A.M.S., M.A.R., J.S., M.H., H.K., M.F., I.S., H.E.M.), Computational Pharmacy (M.S.), and Pharmaceutical Biology (O.P.), Department of P…. Hauptthemen laut MEDLINE: Hypericum, Antineoplastic Agents. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The pregnane X receptor (PXR) is a ligand-activated regulator of cytochrome P450 (CYP)3A enzymes. Among the ligands of human PXR is hyperforin, a constituent of St John's wort (SJW) extracts and potent inducer of human CYP3A4. It was the aim of this study to compare the effect of hyperforin and SJW formulations controlled for its content on CYP3A23-3A1 in rats. Hyperiplant was used as it contains a high hyperforin content and Rebalance because it is controlled for a low hyperforin content. In silico analysis revealed a weak hyperforin-rPXR binding affinity, which was further supported in cell-based reporter gene assays showing no hyperforin-mediated reporter activation in presence of rPXR. However, cellular exposure to Hyperiplant and Rebalance transactivated the CYP3A reporter 3.8-fold and 2.8-fold, respectively, and they induced Cyp3a23-3a1 mRNA expression in rat hepatoma cells compared with control 48-fold and 18-fold, respectively. In Wistar rats treated for 10 days with 400 mg/kg of Hyperiplant, we observed 1.8 times the Cyp3a23-3a1 mRNA expression, a 2.6-fold higher CYP3A23-3A1 protein amount, and a 1.6-fold increase in activity compared with controls. For Rebalance we only observed a 1.8-fold hepatic increase of CYP3A23-3A1 protein compared with control animals. Even though there are differing effects on rCyp3a23-3a1/CYP3A23-3A1 in rat liver reflecting the hyperforin content of the SJW extracts, the modulation is most likely not linked to an interaction of hyperforin with rPXR. SIGNIFICANCE STATEMENT: Treatment with St John's wort (SJW) has been reported to affect CYP3A expression and activity in rats. Our comparative study further supports this finding but shows that the pregnane X receptor-ligand hyperforin is not the driving force for changes in rat CYP3A23-3A1 expression and function in vivo and in vitro. Importantly, CYP3A induction mimics findings in humans, but our results suggest that another so far unknown constituent of SJW is responsible for the expression- and function-modifying effects in rat liver.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HypericumAntineoplastic AgentsRatsHumansAnimalsCytochrome P-450 CYP3APregnane X ReceptorLigandsRats, WistarRNA, MessengerPlant ExtractsPhloroglucinolTerpenes

Substanzen

Cytochrome P-450 CYP3APregnane X ReceptorLigandsAntineoplastic AgentsRNA, MessengerPlant ExtractsCyp3a23-3a1 protein, rathyperforinPhloroglucinolTerpenes

Autor:innen und Institutionen

  • Biopharmacy (A.M.S., M.A.R., J.S., M.H., H.K., M.F., I.S., H.E.M.), Computational Pharmacy (M.S.), and Pharmaceutical Biology (O.P.), Department of Pharmaceutical Sciences, University of Basel, Basel, Switzerland.
  • Biopharmacy (A.M.S., M.A.R., J.S., M.H., H.K., M.F., I.S., H.E.M.), Computational Pharmacy (M.S.), and Pharmaceutical Biology (O.P.), Department of Pharmaceutical Sciences, University of Basel, Basel, Switzerland h.meye…

ORCID-Profile: Henriette E Meyer Zu Schwabedissen

Zitieren

APA

Schäfer, A. M., Rysz, M. A., Schädeli, J., Hübscher, M., Khosravi, H., Fehr, M., Seibert, I., Potterat, O., Smieško, M., & Meyer Zu Schwabedissen, H. E. (2024). St. John’s Wort Formulations Induce Rat CYP3A23-3A1 Independent of Their Hyperforin Content. Molecular Pharmacology. https://doi.org/10.1124/molpharm.123.000725

Vancouver

Schäfer AM, Rysz MA, Schädeli J, Hübscher M, Khosravi H, Fehr M, et al. St. John’s Wort Formulations Induce Rat CYP3A23-3A1 Independent of Their Hyperforin Content. Molecular Pharmacology. 2024. doi:10.1124/molpharm.123.000725

BibTeX
@article{Schfer2024,
  author = {Schäfer, Anima M and Rysz, Marta A and Schädeli, Julia and Hübscher, Michelle and Khosravi, Haleh and Fehr, Michelle and Seibert, Isabell and Potterat, Olivier and Smieško, Martin and Meyer Zu Schwabedissen, Henriette E},
  title = {St. John’s Wort Formulations Induce Rat CYP3A23-3A1 Independent of Their Hyperforin Content},
  journal = {Molecular Pharmacology},
  year = {2024},
  doi = {10.1124/molpharm.123.000725}
}
Kostenlos starten →